None
Quote | Assertio Therapeutics Inc. (NASDAQ:ASRT)
Last: | $1.33 |
---|---|
Change Percent: | 15.65% |
Open: | $1.2 |
Close: | $1.15 |
High: | $1.35 |
Low: | $1.2 |
Volume: | 848,166 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Assertio Therapeutics Inc. (NASDAQ:ASRT)
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
2024-06-27 09:51:48 ET Summary Assertio Holdings, Inc. shares present a significant upside potential due to ongoing turnaround efforts and proven success in monetizing underappreciated pharma assets. The merger with Spectrum Pharmaceuticals saved Assertio from potential collapse a...
Message Board Posts | Assertio Therapeutics Inc. (NASDAQ:ASRT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ASRT News Article - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBI | whytestocks | investorshangout | 04/28/2023 4:35:50 PM |
znewcar1: $ASRT 3% v1,7M+ @6.39 f55,662M Link | znewcar1 | investorshangout | 04/24/2023 3:43:24 PM |
whytestocks: $ASRT News Article - Best Penny Stocks To Buy? 4 To Watch Before November | whytestocks | investorshangout | 10/28/2022 7:05:56 PM |
whytestocks: $ASRT News Article - 7 Penny Stocks to Buy Before the Bull Market Returns | whytestocks | investorshangout | 08/01/2022 12:45:54 PM |
whytestocks: $ASRT News Article - Assertio Holdings, Inc. Partners with BlinkRx to Support Healthcar | whytestocks | investorshangout | 03/31/2022 5:35:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
15.65%Change Percent:
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...
LAKE FOREST, Ill., May 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that its Board of...